These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2851414)

  • 1. A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension.
    Zabludowski J; Rosenfeld J; Akbary MA; Rangoonwala B; Schinzel S
    Curr Med Res Opin; 1988; 11(2):93-106. PubMed ID: 2851414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in cough reflex after treatment with enalapril and ramipril.
    McEwan JR; Choudry N; Street R; Fuller RW
    BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B; Lorenz H; Zahlten R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo.
    Villamil AS; Cairns V; Witte PU; Bertolasi CA
    Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor.
    Griebenow R; Pittrow DB; Weidinger G; Mueller E; Mutschler E; Welzel D
    Blood Press; 1997 Sep; 6(5):299-306. PubMed ID: 9360001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
    Witte PU; Walter U
    Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
    Erhard W; Lindner U; Krall H; Breitstadt A; Pfeiffer C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S160-4. PubMed ID: 1725032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination.
    Thijs L; Celis H; Kiowski W; Löffler K; Middeke M; Schulz W; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):33-8. PubMed ID: 7564362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.
    Homuth V; Faulhaber HD; Loose U; Löffler K; Luft FC
    Am J Cardiol; 1993 Sep; 72(9):666-71. PubMed ID: 8249842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
    Becker RH; Baldes L; Treudler M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril.
    Predel HG; Düsing R; Bäcker A; Kipnowski J; Kramer HJ
    Am J Cardiol; 1987 Apr; 59(10):143D-148D. PubMed ID: 3034023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice.
    Carré A; Vasmant D; Elmalem J; Thiéry P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S141-3. PubMed ID: 1725026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ramipril versus enalapril in patients with mild to moderate essential hypertension.
    Yasky J; Verho M; Erasmus TP; Luus HG; Angela M; Grandin L; Akbary MA; Rangoonwala B
    Br J Clin Pract; 1996 Sep; 50(6):302-10. PubMed ID: 8983318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
    Burris JF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S131-3. PubMed ID: 1725022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension.
    Lenox-Smith AJ; Street RB; Kendall FD
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S150-2. PubMed ID: 1725029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tolerance to Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
    Elmalem J
    Rev Prat; 1990 Jun; 40(18 Suppl):39-44. PubMed ID: 2143597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
    Guyot D; Lemarié JC
    Rev Prat; 1990 Jun; 40(18 Suppl):27-30, 35-8. PubMed ID: 2143596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.